title: Letter by Bergerot et al Regarding Article, "Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".
authors: Hôpital Cardiovasculaire Louis Pradel, Department of Cardiology, Hospices Civils de Lyon, Bron, FranceHôpital Cardiovasculaire Louis Pradel, Centre d'Investigation Clinique 1407, Hospices Civils de Lyon, Bron, France.
authors: Cyrille
authors: C
authors: Bergerot
authors: Hôpital Cardiovasculaire Louis Pradel, Cardiac Surgery Department, Hospices Civils de Lyon, Bron, France.
authors: Fadi
authors: F
authors: Farhat
authors: Hôpital Cardiovasculaire Louis Pradel, Department of Cardiology, Hospices Civils de Lyon, Bron, FranceHôpital Cardiovasculaire Louis Pradel, Centre d'Investigation Clinique 1407, Hospices Civils de Lyon, Bron, France.
authors: Nathan
authors: N
authors: Mewton
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D001026:Coronary Artery Bypass / Q000639:trends*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000601:surgery*; D055502:Secondary Prevention / Q000639:trends*
chemical_list: D000319:Adrenergic beta-Antagonists